Treatment with semaglutide and papaya significantly reduced hyperglycemia and improved the lipid profile
results from the UK survey of British adults are given in Table 20b.1
A subscription is a recurring obligation, and the fine print defines the real cost
Scenario A- GLP-1s become a standard treatment, like statins for cholesterol
et al., The increasing rate of diabetes in Pakistan: A silent killer (2022) IDF, Prevalence of Diabetes in Pakistan (2024) Jastreboff et al., NEJM, Phase 2 obesity trial of retatrutide (2023) Reuters Next generation Lilly weight-loss drug shows added heart, liver benefits (2024) Investopedia / news20 Eli Lilly shares rise after drug helps patients lose more weight than competitors (2023) Lancet Phase 2 trial on T2DM (via ResearchGate summary) PMC meta-analysis: weight/metabolic outcomes of retatrutide Anti-obesity medication (retatrutide entry) News21 (Axios) Extraordinary promise of retatrutide (2023) USA Today (American Diabetes Association summary) News25 (NY Post) re: Phase 3 status and side effects
Chronic intestinal pseudo-obstruction: manifestations, natural history and management